The European Union and India launched negotiations on a bilateral free trade and investment agreement in June 2007. However, between the governments, a number of controversies have been plaguing the talks. Delhi wants Brussels to relax its stringent food safety criteria which penalise Indian farm and fishery exports and to make it easier for Indian professionals to work in the EU. Europe is primarily out to win major openings of India’s services sector and broad liberalisation of foreign investment, while India does not want to discuss allowing European firms to compete in India’s government procurement market.
Indian social movements, including fisherfolk and labour unions, people living with HIV/AIDS and other health activists have been mobilizing against the FTA. International actions and campaigns have particularly targeted the proposed intellectual property provisions of the agreement, and the impact of the FTA on access to medicines.
last update: May 2012
Civil society and public health groups from India, Brazil and several other countries today vehemently objected to the proposed India-European Union Free Trade Agreement (FTA).
In light of the meeting with members of the International Trade Commission of the European Parliament, scheduled for April 9th at the office of the Brazilian Interdisciplinary AIDS Association, the Working Group of Intellectual Property (GTPI) decided to promote a on-line petition (in Portuguese and English) as form of protest against the negotiations of the Free Trade Agreement (FTA) between India and European Union.
The Delhi Network of Positive People (DNP+) is calling on the EU Trade Commissioner to come clean on the demands and pressures being placed by the European Union on the Government of India to accept TRIPS-plus measures that will have a severe, adverse impact on access to safe, effective and affordable medicines in India and across the developing world.
Commerce minister Anand Sharma said on Monday that a proposed free-trade agreement (FTA) with the European Union (EU) would not hurt the generic drugs industry. The minister also said India would attract the same amount of foreign direct investment as last year.
As informal talks have started between India and Europe on the free trade agreement (FTA) in New Delhi since Monday, apprehensions over provisions that could impact early access to generic medicines are being voiced in Thailand.
CENTAD, in partnership with the Heinrich Böll Foundation, have come out recently with 4 reports on trade and gender. The first is a backgrounder (literature review) while the other three are on the gender impact of the EU-India FTA in the fields of agriculture, services and health.
India-EU free-trade pact may limit cheap drugs
India has rejected the European Union’s demand on including social clauses such as labour and environmental standards in the proposed Free Trade Agreement (FTA), saying there are other forums to discuss these issues.
Delhi Network of Positive People protest the EU-India and all FTAs to MPs in India
The European Union expects to clinch a free trade pact with India by October, the EU’s trade chief said Thursday, as the 27-member trading bloc pushes to secure new markets across Asia.